Conmed (CNMD) EBIT Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Conmed | 1.06 Bn | 1.02 Bn | 183.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -61.00 |
| Dec 31, 2025 | 4.00 |
| Sep 30, 2025 | -884.00 |
| Jun 30, 2025 | 2,461.00 |
| Mar 31, 2025 | -119.00 |
| Dec 31, 2024 | 465.00 |
| Sep 30, 2024 | 1,178.00 |
| Jun 30, 2024 | 635.00 |
| Mar 31, 2024 | 588.00 |
| Dec 31, 2023 | 469.00 |
| Sep 30, 2023 | 425.00 |
| Jun 30, 2023 | 79.00 |
| Mar 31, 2023 | -425.00 |
| Dec 31, 2022 | -1,085.00 |
| Sep 30, 2022 | 173.00 |
| Jun 30, 2022 | 234.00 |
| Mar 31, 2022 | 1,060.00 |
| Dec 31, 2021 | 741.00 |
| Sep 30, 2021 | 324.00 |
| Jun 30, 2021 | 610.00 |
| Mar 31, 2021 | 668.00 |
| Dec 31, 2020 | 298.00 |
| Sep 30, 2020 | 358.00 |
| Jun 30, 2020 | -2,032.00 |
| Mar 31, 2020 | 0.00 |
| Dec 31, 2019 | 176.00 |
| Sep 30, 2019 | 756.00 |
| Jun 30, 2019 | -64.00 |
| Mar 31, 2019 | -418.00 |
| Dec 31, 2018 | 270.00 |
| Sep 30, 2018 | 78.00 |
| Jun 30, 2018 | -27.00 |
| Mar 31, 2018 | 6.00 |
| Dec 31, 2017 | 196.00 |
| Sep 30, 2017 | -67.00 |
| Jun 30, 2017 | -251.00 |
| Mar 31, 2017 | -1,010.00 |
| Dec 31, 2016 | 2,861.00 |
| Sep 30, 2016 | -173.00 |
| Jun 30, 2016 | -514.00 |
| Mar 31, 2016 | -746.00 |
| Dec 31, 2015 | -57.00 |
| Sep 30, 2015 | -6.00 |
| Jun 30, 2015 | -130.00 |